| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_805f4bd39d68467aa2b25dfec0900b0e |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-662
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P39-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-662
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-661
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-107
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P39-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-12 |
| filingDate |
2001-11-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2012-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a51662ee53c5a6895bcaded422bc6489 |
| publicationDate |
2012-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
ES-2376305-T3 |
| titleOfInvention |
FORMULATION CONTAINING DERIVATIVES OF TYPE PHOSPHATE OF ELECTRONIC TRANSFER AGENTS. |
| abstract |
An emulsion-shaped composition for therapeutic administration comprising: a) at least one phosphate derivative of a monoelectronic transfer agent; b) at least one phosphate derivative of a dielectronic transfer agent; where the electronic transfer agent is selected from the group consisting of hydroxychromans, stumps and tocotrienols in enantiomeric or racemic forms; quinoles being the reduced forms of vitamin K1 and ubiquinone; hydroxycarotenoids; and ascorbic acid; and where the molar ratio between the phosphate derivative of the monoelectronic transfer agent and the phosphate derivative of the dielectronic transfer agent is in the range of 85:15 to 65:35; and c) a suitable carrier. |
| priorityDate |
2000-11-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |